person · Reporting owner
Gbadegesin Bosede Ikeolu
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EASTMAN CHEMICAL COEMN · Entity 1780 | SVP, CLO & Corporate Secretary | February 24, 2026 | February 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EASTMAN CHEMICAL CO
Report date February 24, 2026 · Filed February 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.12 · Expires 2036-02-23 | Direct | 33,223 |
Reported balance
After 2026-02-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-24 · Grant · Acquired 33,223 · Balance 33,223 F1: One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,571 |
Reported balance
After 2026-02-24 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-24 · Grant · Acquired 4,571 · Balance 4,571 F2: Each restricted stock unit represents a contingent right to receive one share of issuer common stock. F3: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment. |
Filing footnotes · ownership attribution and instrument terms
F1: One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively.
F2: Each restricted stock unit represents a contingent right to receive one share of issuer common stock.
F3: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2026 Filed Feb 26, 2026 21:02 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantRestricted Stock Units · Derivative | 4,571 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-26-000061 · wk-form4_1772139776.xml · derivative · entry 2 Gbadegesin Bosede Ikeolu · CIK 0002036842 · SVP, CLO & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,571 Underlying: Common Stock · 4,571 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of issuer common stock. F3 · derivative.exercise_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment. F3 · derivative.expiration_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:02 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantEmployee Stock Option (right to buy) · Derivative | 33,223 | $0.00 Strike: $77.12 | $0.00 |
DisclosureSEC source: 0000915389-26-000061 · wk-form4_1772139776.xml · derivative · entry 1 Gbadegesin Bosede Ikeolu · CIK 0002036842 · SVP, CLO & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,223 Underlying: Common Stock · 33,223 shares Expires 2036-02-23 F1 · derivative.exercise_date: One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:20 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantRestricted Stock Units · Derivative | 2,762 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-25-000049 · wk-form4_1740432004.xml · derivative · entry 2 Gbadegesin Bosede Ikeolu · CIK 0002036842 · SVP, CLO & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,762 Underlying: Common Stock · 2,762 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of issue common stock. F3 · derivative.exercise_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 20, 2028, subject to continued employment. F3 · derivative.expiration_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 20, 2028, subject to continued employment. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:20 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantEmployee Stock Option (right to buy) · Derivative | 14,460 | $0.00 Strike: $100.56 | $0.00 |
DisclosureSEC source: 0000915389-25-000049 · wk-form4_1740432004.xml · derivative · entry 1 Gbadegesin Bosede Ikeolu · CIK 0002036842 · SVP, CLO & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,460 Underlying: Common Stock · 14,460 shares Expires 2035-02-19 F1 · derivative.exercise_date: One-third of the option becomes exercisable on February 20, 2026, February 20, 2027, and February 20, 2028, respectively. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:03 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantRestricted Stock Units · Derivative | 16,994 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-24-000196 · wk-form4_1727985822.xml · derivative · entry 1 Gbadegesin Bosede Ikeolu · CIK 0002036842 · SVP, CLO & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,994 Underlying: Common Stock · 16,994 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of issuer common stock. F2 · derivative.exercise_date: The restricted stock units will vest and payout in unrestricted shares of Company stock on October 1, 2027, subject to Ms. Gbadegesin's continued employment. F2 · derivative.expiration_date: The restricted stock units will vest and payout in unrestricted shares of Company stock on October 1, 2027, subject to Ms. Gbadegesin's continued employment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.